论文部分内容阅读
目的:分析急性上呼吸道感染患儿抗菌药物临床使用情况,为抗菌药物的合理使用提供参考。方法:抽取2015年3月—2016年3月期间收治的急性上呼吸道感染患儿130例,分析其临床治疗抗菌药物的使用情况。结果:130例患儿均使用抗菌药物治疗,其抗菌药物的使用率为100.00%;使用单一抗菌药物治疗患儿68例占52.31%,无2种或以上抗菌药物联合使用的情况;抗菌药物使用品种有注射用阿莫西林钠-克拉维酸钾、注射用头孢噻肟钠、注射用头孢呋辛钠、阿奇霉素干混悬剂、头孢克肟颗粒和阿莫西林-克拉维酸钾分散片;给药途径有经静脉给药的114例占87.69%、口服给药的16例占12.31%;治疗结局为治愈的121例占93.08%、好转的9例占6.92%。结论:130例急性上呼吸道感染患儿抗菌药物的使用有不合理之处,故需不断采取改进措施以使抗菌药物的使用更趋合理和规范。
Objective: To analyze the clinical use of antibacterials in children with acute upper respiratory tract infection, and to provide reference for the rational use of antibacterials. Methods: A total of 130 children with acute upper respiratory tract infection who were admitted to our hospital from March 2015 to March 2016 were selected for analysis of their clinical use of antimicrobial agents. Results: All the 130 children were treated with antimicrobial agents, with 100.00% antibacterials. A single antimicrobial drug was used in 68 children (52.31%), no combination of two or more antibacterials was used. Antimicrobials Varieties are injection of amoxicillin sodium - potassium clavulanate, cefotaxime sodium for injection, cefuroxime sodium for injection, azithromycin dry suspension, cefixime particles and amoxicillin - potassium clavulanate dispersible tablets; There were 114 cases of intravenous administration of 87.69%, oral administration of 16 cases accounted for 12.31%; treatment outcome was cured 121 cases accounted for 93.08%, improved in 9 cases accounted for 6.92%. Conclusion: The use of antimicrobial agents in 130 children with acute upper respiratory tract infection is unreasonable. Therefore, we must take continuous improvement measures to make the use of antimicrobial agents more reasonable and standardized.